ASCLS eNewsBytes
Sep. 8, 2015

Early flu treatment reduces hospitalization time, disability risk in older people
Infection Control Today
Early treatment of flu-hospitalized people 65 and older with flu anti-viral medications cuts the duration of their hospital stay and reduces their risk of needing extended care after discharge, a new Centers for Disease Control and Prevention study finds. The study is the first to look at the benefits of early anti-viral treatment on preventing the need for extended care in community-dwelling flu-hospitalized people 65 and older.More

Variations in cell programs control cancer and normal stem cells
Whitehead Institute for Biomedical Research via ScienceDaily
In the breast, cancer stem cells and normal stem cells can arise from different cell types and tap into distinct yet related stem cell programs, according to researchers. The differences between these stem cell programs may be significant enough to be exploited by future therapeutics. More

Check out the latest Clinical Lab Investigations: Case Studies for the Laboratory Professional from ASCLS
ASCLS
We have recently added more case studies to our popular CLI Series. Each peer-reviewed case study is designed to take you beyond the laboratory test to investigate the causes of abnormal laboratory results. Download each case study for free, study at your own pace and then purchase the online quiz for $15 (ASCLS member rate) to earn P.A.C.E.® credit. Visit www.ascls.org/CLI for more details.More

Team develops speedy way to determine antibiotic resistance
Arizona State University via Lab Manager
Bacteria's ability to become resistant to antibiotics is a growing issue in healthcare: Resistant strains result in prolonged illnesses and higher mortality rates. One way to combat this is to determine bacteria's antibiotic resistance in a given patient, but that often takes days — and time is crucial in treatment. More

Scientists work on new 'liquid biopsy' for breast cancer
NBC News
VideoBriefBritish scientists say they've got a promising new blood test that might warn breast cancer patients that they're about to have a relapse. It's the latest in a line of so-called liquid biopsies, which seek to find tiny tumor cells circulating in the blood long before they take hold somewhere and grow into a fresh tumor.More

Death toll in Legionnaires' outbreak in Illinois rises to 8
Reuters
An outbreak of Legionnaires' disease has killed an eighth person in Quincy, Illinois, and sickened 41, mostly at a veterans home, health and veterans affairs officials said. The latest death occurred outside the Illinois Veterans' Home, the officials said, adding that three others were sickened in the city and six more at the veterans home, the officials said.More

Health insurers balk at paying for multigene panels while clinical pathology laboratories and physicians pursue evidence of clinical utility
DARK Daily
A conflict is building between patients and health insurers over the reluctance among health plans to pay for new, expensive molecular diagnostic assays and genetic tests that clinical laboratory companies offer. This conflict has caught the attention of the nation's media. More

Electrical bursts to pancreatic cancer cells may help fight tumor
HealthDay News
Using tiny but powerful bursts of electricity to make holes in pancreatic cancer cells may improve survival rates for some patients, new research suggests. Using zaps of electricity in certain patients can "nearly double the survival rate with the best new chemotherapy and chemoradiotherapy," said study author Dr. Robert Martin II, director of surgical oncology at the University of Louisville.More

Potential genetic test to aid autism diagnosis
Medical News Today
The tests were more likely to identify mutations in a subgroup of children with certain physical anomalies, making clinical examination an important way of selecting those children with autism spectrum disorder who could benefit most from genetic testing. "It is incontrovertible that precise diagnoses pave the way to better medical care, improved surveillance, better functional outcomes and informed genetic counseling, often with the possibility of prenatal or preimplantation diagnosis," says an editorial in the same issue of the journal.More